Concepedia

The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation

Fawzia Bardag‐Gorce, Nora E. Riley, Nan Li, R.O Montgomery, Jun Li, Barbara A. French, Samuel W. French

Experimental and Molecular Pathology · 2003 · 34 citations · 25 references

DOI

Concepts

References

25

Aggresomes: A Cellular Response to Misfolded Proteins

Jennifer Johnston, Cristina L. Ward, Ron R. Kopito · The Journal of Cell Biology · 1998 · 2.2K citations · Full text

, , +17

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville et al. · PubMed · 1999 · 1.5K citations

, , +14

Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell et al. · Journal of Clinical Oncology · 2002 · 763 citations

, , +17

The proteasome inhibitor PS-341 in cancer therapy.

B A Teicher, G Ara, Roy S. Herbst et al. · PubMed · 1999 · 473 citations

, , +13

α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome

George K. Tofaris, Robert Layfield, Maria Grazia Spillantini · FEBS Letters · 2001 · 356 citations

, , +17